INTEROR is particularly proud to announce very good news for its manufacturing site in Calais (France).

Following the latest announcements by the President of the French Republic Emmanuel Macron as part of the Plan France 2030 and the challenges of health sovereignty to fight against drug shortages, INTEROR will acquire a new modern industrial unit and thus build its 6th multipurpose synthesis building.

These additional capacities will be available in early 2025 and will make it possible to deliver Organic Intermediates not only for the health and personal care ingredient industries but also for specialty chemicals customers with whom we already have great projects.
This industrial investment represents a total cost of €22 million, including €4 million in aid from the French State.

Ultimately, nearly 30 additional jobs will be created for this project.

"Our most sincere thanks go to all our partners: French State, Hauts de France Region, Calais Agglomeration, as well as to our loyal shareholders and banks", said Geoffroy Waroqueaux, Chairman